You are using an older browser version. Please use a supported version for the best MSN experience.

Rydex Biotechnology Inv

RYOIX
79.58
-0.81
-1.01%
9/28/2016
5 Years
  • Previous Close

    80.39

  • Net Assets

    275.04M

  • Yield

    0.00%

  • Front load

    None

  • Expenses

    1.32%

  • Category

    Health

  • Morningstar Risk

    High

  • Morningstar Rating ★★★
Profile

Name of Issuer

Rydex Funds

Fund Style

Open

Fund Manager

Ryan Harder

Investment Style

Medium Growth

The investment seeks to provide capital appreciation. Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Purchase Information

Initial Purchase 2,500
Initial Purchase: IRA 1,000
Initial Purchase: AIP NA

Inception

4/1/1998

AdChoices
AdChoices
image beaconimage beaconimage beacon